As new medications for diabetes come to market there is always a question as to how well they will work when added to other medications. This month, we have a slide presentation from the ADA, outlining the rationale for mating DPP-4 inhibitors with SGLT-2 inhibitors.
Read More »Diabetes In Control
SGLT2 Inhibitors as Add-On for Poorly Controlled Patients on DPP-4s and Metformin
As the diabetes epidemic continues to grow, practitioners are increasingly searching for medication solutions that can help patients to better manage their diabetes. This month, we have a recent slides series from the ADA showing the positive effects of adding-on SGLT-2 inhibitors to the medication regimen of patients on DPP-4’s …
Read More »Letter from the Editor #746
This week we have an item about the increased use of gastric sleeve for weight reduction and the reversal of diabetes. This newer procedure is actually becoming preferred for overweight patients. Although this may sound like a similar device to a Lap Band it is actually a significant surgery where …
Read More »FDA Approves Weight Loss Drug Contrave
FDA Approves Weight Loss Drug Contrave. See this week’s Item #4. FDA Advisory Panel Recommends Approval of Novo Nordisk’s liraglutide (used now as Victoza to treat type 2 diabetes ) for use in chronically obese patients with at least one weight-related health issue. More news to come. The new drug would be …
Read More »Prediabetes and Obesity Tied to Overall Increased Risk for Cancer
"Lifestyle intervention (weight control, stop smoking and healthy diet, etc.) should be suggested earlier and recommended as the mainstay of treatment for prediabetes in the general population," said researcher Dr. Yuli Huang, who also said data on the effects of treatment with metformin are needed. See this week’s Item #1.
Read More »Cardiac Protein May Contribute to Higher Heart Risk in Diabetes
A study found diabetes patients were more than twice as likely as people without the disease to exhibit elevated troponin levels. Researchers also found diabetes patients had a six fold increased odds of dying from heart failure and were four times as likely to die of a heart attack during …
Read More »Statins Can Protect against Diabetes-related Nerve, Retina Damage
Diabetes patients who took statins had lower odds of developing diabetes-related nerve and retinal damage compared with nonusers, according to a study of data involving more than 60,000 patients in Denmark. Statin use was also associated with reduced risk of gangrene. The Lancet Diabetes & Endocrinology. Sept. 9, 2014
Read More »Prediabetes Correlates with Greater Cancer Risk
The meta-analysis also showed risks for certain cancers increased 22% with a prediabetes diagnosis….
Read More »High BMI Increases Risk for Ten Cancers
Higher BMI increased individuals’ risks for 10 common cancers, according to results of a population-based cohort study conducted in the UK….
Read More »Type 2 Diabetes Diagnosis Needs to Be Changed: Prediabetes=Diabetes
A long-term UK study revealed that in order to prevent poorer health outcomes, changes need to be made to the current way of diagnosing patients with type 2 diabetes….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.